RHEOS
Dead / Cancelled — Cancelled — Section 8 (as of 10 Jan 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87614513
- Registration number
- 5504894
- Mark type
- Stylized text
- Filed
- 19 Sept 2017
- Published for opposition
- 06 Feb 2018
- Registered
- 26 Jun 2018
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 042 — Scientific and technological services: Biomedical, pharmaceutical and scientific research in the field of autoimmunity and oncology; pharmaceutical drug services, namely, pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; product development in the field of autoimmunity and oncology; research and development of human therapeutics using cellular harnessing
Owner
- RHEOS MEDICINES, INC., Cambridge, MA, US
- RHEOS MEDICINES, INC., Boston, MA, US
- RHEOS MEDICINES, INC., Boston, MA, US
Prosecution history
- 10 Jan 2025 — CANCELLED SEC. 8 (6-YR)
- 26 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Jan 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jan 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Jul 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Jul 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 22 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Apr 2018 — USE AMENDMENT FILED
- 03 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Apr 2018 — TEAS STATEMENT OF USE RECEIVED
- 03 Apr 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Feb 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED